366 related articles for article (PubMed ID: 14236800)
1. A CONTROLLED EVALUATION OF BUTAPERAZINE IN CHRONIC SCHIZOPHRENIC PATIENTS.
BISHOP MP; GALLANT DM; NESSELHOF W; SPREHE DJ
Dis Nerv Syst; 1964 Nov; 25():674-83. PubMed ID: 14236800
[No Abstract] [Full Text] [Related]
2. SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.
BISHOP MP; GALLANT DM
Arch Gen Psychiatry; 1965 Aug; 13():155-62. PubMed ID: 14314761
[No Abstract] [Full Text] [Related]
3. WITHDRAWAL SYMPTOMS AFTER ABRUPT CESSATION OF ANTIPSYCHOTIC COMPOUNDS: CLINICAL CONFIRMATION IN CHRONIC SCHIZOPHRENICS.
GALLANT DM; EDWARDS CG; BISHOP MP; GALBRAITH GC
Am J Psychiatry; 1964 Nov; 121():491-3. PubMed ID: 14218408
[No Abstract] [Full Text] [Related]
4. BEHAVIORAL IMPROVEMENT IN THE OLDER SCHIZOPHRENIC PATIENT: DRUG AND SOCIAL THERAPIES.
HONIGFELD G; ROSENBLUM MP; BLUMENTHAL IJ; LAMBERT HL; ROBERTS AJ
J Am Geriatr Soc; 1965 Jan; 13():57-72. PubMed ID: 14256223
[No Abstract] [Full Text] [Related]
5. [EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
BOHACEK N; HAJNSEK F; SARTORIUS N
Fortschr Neurol Psychiatr Grenzgeb; 1963 Oct; 31():565-70. PubMed ID: 14095902
[No Abstract] [Full Text] [Related]
6. PERSONALITY FACTORS IN VARIABILITY OF RESPONSE TO PHENOTHIAZINES.
HENINGER G; DIMASCIO A; KLERMAN GL
Am J Psychiatry; 1965 May; 121():1091-4. PubMed ID: 14283305
[No Abstract] [Full Text] [Related]
7. WITHDRAWAL OF LONG-TERM PHENOTHIAZINES FROM CHRONICALLY HOSPITALIZED PSYCHIATRIC PATIENTS.
MARJERRISON G; IRVINE D; STEWART CN; WILLIAMS R; MATHEU H; DEMAY M
Can Psychiatr Assoc J; 1964 Aug; 9():290-8. PubMed ID: 14178678
[No Abstract] [Full Text] [Related]
8. HEMODYNAMIC EFFECTS OF IMIPRAMINE, ACETOPHENAZINE, AND TRIFLUOPERAZINE IN GERIATRIC PSYCHIATRY.
HONIGFELD G; NEWHALL PN
Dis Nerv Syst; 1965 Jul; 26():427-9. PubMed ID: 14321267
[No Abstract] [Full Text] [Related]
9. THIOPROPERAZINE IN CHRONIC SCHIZOPHRENIA.
HORDERN A; KING A; HOLT NF; COLLINS HJ; TOUSSAINT J
Br J Psychiatry; 1964 Jul; 110():531-9. PubMed ID: 14153363
[No Abstract] [Full Text] [Related]
10. EFFECTS OF ACETOPHENAZINE DIMALEATE ON PARANOID SYMPTOMATOLOGY IN FEMALE GERIATRIC PATIENTS: DOUBLE-BLIND STUDY.
SHEPPARD C; BHATTACHARYYA A; DIGIACOMO M; MERLIS S
J Am Geriatr Soc; 1964 Sep; 12():884-8. PubMed ID: 14212064
[No Abstract] [Full Text] [Related]
11. NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
Faurbye A; Rasch PJ; Petersen PB; Brandborg G; Pakkenberg H
Acta Psychiatr Scand; 1964; 40(1):10-27. PubMed ID: 14217630
[No Abstract] [Full Text] [Related]
12. A COMPARISON OF SKF-7261 AND TRIFLUOPERAZINE (STELAZINE) IN THE TREATMENT OF CHRONIC SCHIZOPHRENIC PATIENTS.
BISHOP MP; BUDDINGTON RW; ROBINSON WG; SILVA F
J Neuropsychiatr; 1963 Oct; 4():28-32. PubMed ID: 14089790
[No Abstract] [Full Text] [Related]
13. [COMPARATIVE STUDY OF BUTAPERAZINE AND PROCHLORPERAZINE IN CHRONIC SCHIZOPHRENIA].
RAJOTTE P; BORDELEAU JM; TETREAULT L
Can Psychiatr Assoc J; 1965 Feb; 10():25-34. PubMed ID: 14278880
[No Abstract] [Full Text] [Related]
14. Sensitivity to a phenothiazine (butaperazine).
Simpson GM; Laska E
Can Psychiatr Assoc J; 1968 Dec; 13(6):499-506. PubMed ID: 4387257
[No Abstract] [Full Text] [Related]
15. CHANGES IN SCHIZOPHRENIC PSYCHOPATHOLOGY AND WARD BEHAVIOUR AS A FUNCTION OF PHENOTHIAZINE TREATMENT.
GOLDBERG SC; KLERMAN GL; COLE JO
Br J Psychiatry; 1965 Feb; 111():120-33. PubMed ID: 14270524
[No Abstract] [Full Text] [Related]
16. EVALUATION OF A NEW PHENOTHIAZINE DERIVATIVE IN THE TREATMENT OF SCHIZOPHRENIA.
GERZ HO
Am J Psychiatry; 1964 Aug; 121():174-6. PubMed ID: 14194215
[No Abstract] [Full Text] [Related]
17. PERSISTENT ORAL DYSKINESIA IN TREATMENT WITH PHENOTHIAZINE DERIVATIVES.
JOYSTON-BECHAL MP
Lancet; 1965 Mar; 1(7385):600-1. PubMed ID: 14250095
[No Abstract] [Full Text] [Related]
18. A LONG-TERM CLINICAL EVALUATION OF A NEW TRANQUILLIZER--TOLNATE.
FISMER DF
S Afr Med J; 1964 Nov; 38():911-3. PubMed ID: 14225676
[No Abstract] [Full Text] [Related]
19. Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital.
BRUNE GG; KOBAYASHI T; BULL C; TOURLENTES TT; HIMWICH HE
Compr Psychiatry; 1962 Oct; 3():292-6. PubMed ID: 13873984
[No Abstract] [Full Text] [Related]
20. A PRELIMINARY EVALUATION OF SKF 20,716 (PROPERICIAZINE) IN CHRONIC SCHIZOPHRENIC PATIENTS.
GALLANT DM; BISHOP MP; GALLANT JC
Curr Ther Res Clin Exp; 1964 Sep; 6():597-8. PubMed ID: 14208737
[No Abstract] [Full Text] [Related]
[Next] [New Search]
